SEC Form 4 · Updated Daily

BCYC

Insider and institutional ownership derived from SEC Form 4 filings. Click any owner to see their holdings across every company they’ve filed on, and how their position has changed over time.

FinancialsOwnership

Current Reporting Owners

OwnerRoleShares OwnedAs OfLast Activity
GLAXOSMITHKLINE PLC10%+ Owner1,913,6782020-07-14S
Novartis Bioventures Ltd10%+ Owner1,769,6412019-05-28P
NOVARTIS AG10%+ Owner1,769,6412019-05-28P

Recent Filings

DateOwnerActivitySharesPriceOwned After
2020-07-15GLAXOSMITHKLINE PLCOpen-market sale78$19.251,910,531
2020-07-15GLAXOSMITHKLINE PLCOpen-market sale3,069$19.401,910,609
2020-07-14GLAXOSMITHKLINE PLCOpen-market sale1,597$19.271,913,678
2019-05-28GLAXOSMITHKLINE PLCConversion (derivative)445,323$0.000
2019-05-28GLAXOSMITHKLINE PLCConversion (derivative)625,049$0.000
2019-05-28GLAXOSMITHKLINE PLCOpen-market buy385,714$14.001,915,275
2019-05-28GLAXOSMITHKLINE PLCConversion636,366—1,529,561
2019-05-28GLAXOSMITHKLINE PLCConversion893,195—893,195
2019-05-28NOVARTIS AGConversion (derivative)636,366—0
2019-05-28NOVARTIS AGOption exercise (out-of-money) (derivative)71,450—0
2019-05-28NOVARTIS AGConversion (derivative)893,195—0
2019-05-28NOVARTIS AGOpen-market buy168,630$14.001,769,641
2019-05-28NOVARTIS AGConversion636,366—1,601,011
2019-05-28NOVARTIS AGOption exercise (out-of-money)71,450—964,645
2019-05-28NOVARTIS AGConversion893,195—893,195
2019-05-28Novartis Bioventures LtdConversion (derivative)636,366—0
2019-05-28Novartis Bioventures LtdOption exercise (out-of-money) (derivative)71,450—0
2019-05-28Novartis Bioventures LtdConversion (derivative)893,195—0
2019-05-28Novartis Bioventures LtdOpen-market buy168,630$14.001,769,641
2019-05-28Novartis Bioventures LtdConversion636,366—1,601,011
2019-05-28Novartis Bioventures LtdOption exercise (out-of-money)71,450—964,645
2019-05-28Novartis Bioventures LtdConversion893,195—893,195

Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.